Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released Aug 14, 2026, after the close
10-Q filed Aug 14, 2026, 45 days after period end · 0000926617-26-000054
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.05M | $2.40M | $2.42M | $2.49M |
| Net Income | -$2.42M | -$2.67M | -$3.53M | -$2.32M |
| EPS Diluted | -$0.05 |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.07 |
| -$0.28 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
